Form 4: Cencora Director Acquires Shares via RSU Grant

Cencora Director Lauren M. Tyler acquired 89 shares of common stock as part of her non-employee director compensation program.

Summary

• Lauren M. Tyler, a Director of Cencora, Inc. (COR), acquired 89 shares of common stock on November 1, 2025.
• The acquisition was a grant of Restricted Stock Units (RSUs) received in lieu of a $30,000 quarterly cash retainer.
• The shares were acquired at a price of $337.81 per share, totaling approximately $30,064.09.
• Following this transaction, Lauren M. Tyler beneficially owns 3,069 shares of Cencora common stock.
• The delivery of shares from such grants was deferred until March 1, 2020, as per the Registrant's Non-Employee Director Compensation Program.

Sentiment

Score: 6

Explanation: Slightly positive. A director receiving equity as compensation is a routine event that aligns management interests with shareholders, but it's not a significant discretionary investment.

Positives

• A director's acquisition of shares, even as compensation, aligns their interests with those of shareholders.
• The use of Restricted Stock Units (RSUs) for compensation encourages long-term commitment and performance.

Future Outlook

This filing does not contain forward-looking statements or guidance, as it is a report of a past insider transaction.

Industry Context

Insider transactions, such as director stock acquisitions, are common in publicly traded companies. They provide insights into management's alignment with shareholder interests, though this specific transaction is a routine compensation event rather than a discretionary open-market purchase.

Comparison to Industry Standards

• The practice of compensating non-employee directors with equity, such as Restricted Stock Units (RSUs), is a standard corporate governance practice across industries, including the pharmaceutical and healthcare services sector where Cencora operates.
• The value of the RSU grant ($30,000 quarterly retainer) is within the typical range for non-executive director compensation at large-cap companies, comparable to peers like Cardinal Health (CAH) or McKesson Corporation (MCK) which also utilize a mix of cash and equity for director remuneration.

Corporate Governance

Related Party Transactions

• The acquisition of shares by a director as part of their compensation package is a related-party transaction, structured under the company's established Non-Employee Director Compensation Program.

Stakeholder Impact

• Shareholders: The equity grant to a director can be seen as a positive signal of alignment between management and shareholder interests, potentially fostering long-term value creation.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 reports a routine compensation-related acquisition of shares by a director. While it indicates alignment of interests, it is not a significant discretionary purchase or sale that would typically warrant a change in investment recommendation. The transaction is a standard part of director remuneration and does not provide new fundamental information to alter the investment thesis for Cencora.

Keywords

Cencora, COR, Form 4, Insider Transaction, Director Compensation, Restricted Stock Units, Equity Grant, Stock Acquisition